| Syntheses and therapeutic potential of hydroxamic acid based siderophores and analogs MJ Miller Chemical Reviews 89 (7), 1563-1579, 1989 | 446 | 1989 |
| T cell activation by lipopeptide antigens DB Moody, DC Young, TY Cheng, JP Rosat, C Roura-Mir, PB O'Connor, ... Science 303 (5657), 527-531, 2004 | 307 | 2004 |
| Studies and syntheses of siderophores, microbial iron chelators, and analogs as potential drug delivery agents JM Roosenberg II, YM Lin, Y Lu, MJ Miller Current medicinal chemistry 7 (2), 159-197, 2000 | 299 | 2000 |
| Development and applications of amino acid-derived chiral acylnitroso hetero Diels-Alder reactions PF Vogt, MJ Miller Tetrahedron 54 (8), 1317-1348, 1998 | 298 | 1998 |
| Hydroxamate approach to the synthesis of. beta.-lactam antibiotics MJ Miller Accounts of Chemical Research 19 (2), 49-56, 1986 | 262 | 1986 |
| The Nitrosocarbonyl Hetero‐Diels–Alder Reaction as a Useful Tool for Organic Syntheses BS Bodnar, MJ Miller Angewandte Chemie International Edition 50 (25), 5630-5647, 2011 | 257 | 2011 |
| Synthesis of. beta.-lactams from substituted hydroxamic acids MJ Miller, PG Mattingly, MA Morrison, JF Kerwin Jr Journal of the American Chemical Society 102 (23), 7026-7032, 1980 | 217 | 1980 |
| Advent of Imidazo[1,2-a]pyridine-3-carboxamides with Potent Multi- and Extended Drug Resistant Antituberculosis Activity GC Moraski, LD Markley, PA Hipskind, H Boshoff, S Cho, SG Franzblau, ... ACS medicinal chemistry letters 2 (6), 466-470, 2011 | 196 | 2011 |
| A dual read-out assay to evaluate the potency of compounds active against Mycobacterium tuberculosis J Ollinger, MA Bailey, GC Moraski, A Casey, S Florio, T Alling, MJ Miller, ... PloS one 8 (4), e60531, 2013 | 175 | 2013 |
| Iron transport-mediated drug delivery: practical syntheses and in vitro antibacterial studies of tris-catecholate siderophore–aminopenicillin conjugates reveals selectively … C Ji, PA Miller, MJ Miller Journal of the American Chemical Society 134 (24), 9898-9901, 2012 | 175 | 2012 |
| Design, synthesis, and study of a mycobactin− artemisinin conjugate that has selective and potent activity against tuberculosis and malaria MJ Miller, AJ Walz, H Zhu, C Wu, G Moraski, U Möllmann, EM Tristani, ... Journal of the American chemical society 133 (7), 2076-2079, 2011 | 174 | 2011 |
| Microbial iron chelators as drug delivery agents: the rational design and synthesis of siderophore-drug conjugates MJ Miller, F Malouin Accounts of chemical research 26 (5), 241-249, 1993 | 173 | 1993 |
| Structure–activity relationship of new anti-tuberculosis agents derived from oxazoline and oxazole benzyl esters GC Moraski, M Chang, A Villegas-Estrada, SG Franzblau, U Möllmann, ... European journal of medicinal chemistry 45 (5), 1703-1716, 2010 | 165 | 2010 |
| Exploiting bacterial iron acquisition: siderophore conjugates C Ji, RE Juárez-Hernández, MJ Miller Future medicinal chemistry 4 (3), 297-313, 2012 | 162 | 2012 |
| Is drug release necessary for antimicrobial activity of siderophore-drug conjugates? Syntheses and biological studies of the naturally occurring salmycin “Trojan Horse … TA Wencewicz, U Möllmann, TE Long, MJ Miller Biometals 22, 633-648, 2009 | 161 | 2009 |
| Titanium trichloride reduction of substituted N-hydroxy-2-azetidinones and other hydroxamic acids PG Mattingly, MJ Miller The Journal of Organic Chemistry 45 (3), 410-415, 1980 | 149 | 1980 |
| Molecular mechanism of lipopeptide presentation by CD1a DM Zajonc, MDM Crispin, TA Bowden, DC Young, TY Cheng, J Hu, ... Immunity 22 (2), 209-219, 2005 | 147 | 2005 |
| Trihydroxamate siderophore–fluoroquinolone conjugates are selective sideromycin antibiotics that target Staphylococcus aureus TA Wencewicz, TE Long, U Möllmann, MJ Miller Bioconjugate chemistry 24 (3), 473-486, 2013 | 145 | 2013 |
| Total synthesis of a mycobactin S, a siderophore and growth promoter of Mycobacterium smegmatis, and determination of its growth inhibitory activity against Mycobacterium … J Hu, MJ Miller Journal of the American Chemical Society 119 (15), 3462-3468, 1997 | 140 | 1997 |
| N-((1-Benzyl-1H-1,2,3-triazol-4-yl)methyl)arylamide as a New Scaffold that Provides Rapid Access to Antimicrotubule Agents: Synthesis and Evaluation of … JA Stefely, R Palchaudhuri, PA Miller, RJ Peterson, GC Moraski, ... Journal of medicinal chemistry 53 (8), 3389-3395, 2010 | 138 | 2010 |
